Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Diabetes and Breast Cancer Subtypes.

Bronsveld HK, Jensen V, Vahl P, De Bruin ML, Cornelissen S, Sanders J, Auvinen A, Haukka J, Andersen M, Vestergaard P, Schmidt MK.

PLoS One. 2017 Jan 11;12(1):e0170084. doi: 10.1371/journal.pone.0170084. eCollection 2017.

2.

Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.

Uusitalo E, Kallionpää RA, Kurki S, Rantanen M, Pitkäniemi J, Kronqvist P, Härkönen P, Huovinen R, Carpen O, Pöyhönen M, Peltonen S, Peltonen J.

Br J Cancer. 2017 Jan 17;116(2):211-217. doi: 10.1038/bjc.2016.403. Epub 2016 Dec 8.

3.

Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients.

Sherman ME, Ichikawa L, Pfeiffer RM, Miglioretti DL, Kerlikowske K, Tice J, Vacek PM, Gierach GL.

PLoS One. 2016 Aug 25;11(8):e0160966. doi: 10.1371/journal.pone.0160966. eCollection 2016.

4.

Molecular subtypes of breast carcinoma in Saudi Arabia. A retrospective study.

Alnegheimish NA, Alshatwi RA, Alhefdhi RM, Arafah MM, AlRikabi AC, Husain S.

Saudi Med J. 2016 May;37(5):506-12. doi: 10.15537/smj.2016.5.15000.

5.

Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry.

Iwamoto T, Kumamaru H, Miyata H, Tomotaki A, Niikura N, Kawai M, Anan K, Hayashi N, Masuda S, Tsugawa K, Aogi K, Ishida T, Masuoka H, Iijima K, Matsuoka J, Doihara H, Kinoshita T, Nakamura S, Tokuda Y.

Breast Cancer Res Treat. 2016 Apr;156(3):485-494. doi: 10.1007/s10549-016-3770-7. Epub 2016 Apr 5.

6.

Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.

Chen Y, Klingen TA, Wik E, Aas H, Vigeland E, Liestøl K, Garred Ø, Mæhlen J, Akslen LA, Lømo J.

Diagn Pathol. 2014 Dec 19;9:230. doi: 10.1186/s13000-014-0230-8.

7.

Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.

Chlebowski RT, Anderson GL.

Steroids. 2014 Nov;90:53-9. doi: 10.1016/j.steroids.2014.06.001. Epub 2014 Jun 6. Review.

8.

Long-term exposure to dietary sources of genistein induces estrogen-independence in the human breast cancer (MCF-7) xenograft model.

Andrade JE, Ju YH, Baker C, Doerge DR, Helferich WG.

Mol Nutr Food Res. 2015 Mar;59(3):413-23. doi: 10.1002/mnfr.201300780. Epub 2014 Feb 24.

9.

Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.

Arjonen A, Kaukonen R, Mattila E, Rouhi P, Högnäs G, Sihto H, Miller BW, Morton JP, Bucher E, Taimen P, Virtakoivu R, Cao Y, Sansom OJ, Joensuu H, Ivaska J.

J Clin Invest. 2014 Mar;124(3):1069-82.

10.

Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.

Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C, Qi L, Yasmeen S, Newcomb PA, Prentice RL.

J Natl Cancer Inst. 2013 Apr 17;105(8):526-35. doi: 10.1093/jnci/djt043. Epub 2013 Mar 29.

11.

Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.

Laine A, Sihto H, Come C, Rosenfeldt MT, Zwolinska A, Niemelä M, Khanna A, Chan EK, Kähäri VM, Kellokumpu-Lehtinen PL, Sansom OJ, Evan GI, Junttila MR, Ryan KM, Marine JC, Joensuu H, Westermarck J.

Cancer Discov. 2013 Feb;3(2):182-97. doi: 10.1158/2159-8290.CD-12-0292. Epub 2013 Jan 10.

12.

Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series.

Crispo A, Barba M, D'Aiuto G, De Laurentiis M, Grimaldi M, Rinaldo M, Caolo G, D'Aiuto M, Capasso I, Esposito E, Amore A, Di Bonito M, Botti G, Montella M.

BMC Cancer. 2013 Jan 10;13:15. doi: 10.1186/1471-2407-13-15.

13.

Prognosis in women with interval breast cancer: population based observational cohort study.

Kalager M, Tamimi RM, Bretthauer M, Adami HO.

BMJ. 2012 Nov 16;345:e7536. doi: 10.1136/bmj.e7536.

14.

Changing concepts: Menopausal hormone therapy and breast cancer.

Chlebowski RT, Anderson GL.

J Natl Cancer Inst. 2012 Apr 4;104(7):517-27. doi: 10.1093/jnci/djs014. Epub 2012 Mar 16. Review.

15.
16.

A three-gene model to robustly identify breast cancer molecular subtypes.

Haibe-Kains B, Desmedt C, Loi S, Culhane AC, Bontempi G, Quackenbush J, Sotiriou C.

J Natl Cancer Inst. 2012 Feb 22;104(4):311-25. doi: 10.1093/jnci/djr545. Epub 2012 Jan 18.

17.

Long-term prognosis of breast cancer detected by mammography screening or other methods.

Lehtimäki T, Lundin M, Linder N, Sihto H, Holli K, Turpeenniemi-Hujanen T, Kataja V, Isola J, Joensuu H, Lundin J.

Breast Cancer Res. 2011;13(6):R134. doi: 10.1186/bcr3080. Epub 2011 Dec 28.

18.

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.

Sihto H, Lundin J, Lundin M, Lehtimäki T, Ristimäki A, Holli K, Sailas L, Kataja V, Turpeenniemi-Hujanen T, Isola J, Heikkilä P, Joensuu H.

Breast Cancer Res. 2011 Sep 13;13(5):R87. doi: 10.1186/bcr2944.

19.

Impact of mammographic screening on the detection of good and poor prognosis breast cancers.

Esserman LJ, Shieh Y, Rutgers EJ, Knauer M, Retèl VP, Mook S, Glas AM, Moore DH, Linn S, van Leeuwen FE, van 't Veer LJ.

Breast Cancer Res Treat. 2011 Dec;130(3):725-34. doi: 10.1007/s10549-011-1748-z. Epub 2011 Sep 4. Review.

20.

Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survival.

Brewster AM, Thompson P, Sahin AA, Do K, Edgerton M, Murray JL, Tsavachidis S, Zhou R, Liu Y, Zhang L, Mills G, Bondy M.

Cancer Prev Res (Phila). 2011 Oct;4(10):1609-16. doi: 10.1158/1940-6207.CAPR-10-0361. Epub 2011 Jul 27.

Supplemental Content

Support Center